Work

Phase II study of VNP40101M in patients (pts) with acute myelogenous leukemia (AML) and high-risk myelodysplasia (MDS)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.6541

Authors: F. J. Giles, S. O’Brien, N. Vey, E. Feldman, D. Rizzieri, K. D. Khan, S. F. Bilgrami, G. Verhoef, G. Mufti, B. Johnson, J. Karp

Institutions: Johns Hopkins University, Duke University, King's College London, Cornell University, Institut Paoli-Calmettes, King's College Hospital, Weill Cornell Medicine, Vion Pharmaceuticals (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2275044356

Cites:

Cited by: 4

Related to: 10